Tuberculosis treatment adherence—consistent and complete intake of prescribed anti-tubercular drugs—is central to achieving favourable outcomes, including cure, prevention of relapse and avoidance of ...
We conducted a phase 3, open-label, pragmatic, randomized, controlled noninferiority trial in South Africa to assess a 6-month treatment strategy for pulmonary rifampicin-resistant tuberculosis.
Worldwide, approximately 2 million children younger than 15 years of age are infected with multidrug-resistant (MDR) Mycobacterium tuberculosis, with MDR tuberculosis developing in approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results